Sharma, A., McKeithan, W. L., Serrano, R., Kitani, T., Burridge, P. W., del Álamo, J. C., . . . Wu, J. C. (2018). Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nat Protoc.
Citação norma ChicagoSharma, Arun, Wesley L. McKeithan, Ricardo Serrano, Tomoya Kitani, Paul W. Burridge, Juan C. del Álamo, Mark Mercola, and Joseph C. Wu. "Use of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes to Assess Drug Cardiotoxicity." Nat Protoc 2018.
Citação norma MLASharma, Arun, et al. "Use of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes to Assess Drug Cardiotoxicity." Nat Protoc 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.